Synnerva Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Synnerva General Information

Description

Developer of central nervous system drug composition designed to increase CNS efficacy and reduce side effects. The company's composition uses a method based on a combination of generic, FDA approved API's with stimulators of vagal afferents to produce low or sub-therapeutic doses, enabling patients and medical practitioners to significantly reduce the effective doses and eliminate neurological side effects.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Rehov Wadi El Haj 13
  • Nazareth 1603100
  • Israel
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • Rehov Wadi El Haj 13
  • Nazareth 1603100
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synnerva Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Oct-2020 Completed Out of Business
1. Early Stage VC 01-Apr-2020 Completed Startup
To view Synnerva’s complete valuation and funding history, request access »

Synnerva Patents

Synnerva Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3562477-A1 Methods and compositions for potentiating cns drugs and reducing their side effects Inactive 29-Dec-2016
EP-3562477-A4 Methods and compositions for potentiating cns drugs and reducing their side effects Inactive 29-Dec-2016
US-20200188388-A1 Methods and compositions for potentiating cns drugs and reducing their side effects Inactive 29-Dec-2016
EP-3558378-A1 Low dose drug combinations for use in preventing and treating neuronal damage Inactive 22-Dec-2016
EP-3558378-A4 Low dose drug combinations for use in preventing and treating neuronal damage Inactive 22-Dec-2016 A61K31/133
To view Synnerva’s complete patent history, request access »

Synnerva FAQs

  • When was Synnerva founded?

    Synnerva was founded in 2019.

  • Where is Synnerva headquartered?

    Synnerva is headquartered in Nazareth, Israel.

  • What industry is Synnerva in?

    Synnerva’s primary industry is Drug Discovery.

  • Is Synnerva a private or public company?

    Synnerva is a Private company.

  • What is Synnerva’s current revenue?

    The current revenue for Synnerva is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process